NTLA-2001
Intellia Therapeutics,medtronic
[]
by day 28, all patients achieved #ttr reductions of at least 90% those in the nyha iii 0.7 mg/kg and #nyha i/ii 1.0 mg/kg cohorts achieved 94% and 92% ttr reductions, respectively, at 4 month the nyha i/ii 0.7 mg/kg group had achieved 93% ttr reductions at 6 month
#aha22
Cardiologist FACC, FESC | Physician-scientist @UVMHealth | Nature Lover?? | #HeartFailure???????| #HFA & #EACVI Committee @escardio | Content Catalyst in @TCTMD